These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 16505120)
1. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities. Li PK; Pandit B; Sackett DL; Hu Z; Zink J; Zhi J; Freeman D; Robey RW; Werbovetz K; Lewis A; Li C Mol Cancer Ther; 2006 Feb; 5(2):450-6. PubMed ID: 16505120 [TBL] [Abstract][Full Text] [Related]
2. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide. Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents. Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120 [TBL] [Abstract][Full Text] [Related]
5. A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents. Romagnoli R; Oliva P; Salvador MK; Manfredini S; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Rruga F; Mariotto E; Viola G; Bortolozzi R Eur J Med Chem; 2021 Mar; 214():113229. PubMed ID: 33550186 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors. Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616 [TBL] [Abstract][Full Text] [Related]
7. Tubulin-polymerization inhibitors derived from thalidomide. Inatsuki S; Noguchi T; Miyachi H; Oda S; Iguchi T; Kizaki M; Hashimoto Y; Kobayashi H Bioorg Med Chem Lett; 2005 Jan; 15(2):321-5. PubMed ID: 15603947 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607 [TBL] [Abstract][Full Text] [Related]
9. 4- and 5-aroylindoles as novel classes of potent antitubulin agents. Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action. Pandit B; Hu Z; Chettiar SN; Zink J; Xiao Z; Etter JP; Bhasin D; Li PK Bioorg Med Chem Lett; 2013 Dec; 23(24):6902-4. PubMed ID: 24169233 [TBL] [Abstract][Full Text] [Related]
15. Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents. Mehndiratta S; Chiang YF; Lai MJ; Lee HY; Chen MC; Kuo CC; Chang CY; Chang JY; Liou JP Bioorg Med Chem; 2014 Sep; 22(17):4917-23. PubMed ID: 25059503 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of (R)- and (S)-N-(4-Methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium chloride as potent cytotoxic antitubulin agents. Gangjee A; Zhao Y; Hamel E; Westbrook C; Mooberry SL J Med Chem; 2011 Sep; 54(17):6151-5. PubMed ID: 21786793 [TBL] [Abstract][Full Text] [Related]
17. Modification of the phenyl ring B of phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates by pyridinyl moiety leads to novel antimitotics targeting the colchicine-binding site. Ouellette V; Bouzriba C; Chavez Alvarez AC; Hamel-Côté G; Fortin S Bioorg Med Chem Lett; 2024 Jun; 105():129745. PubMed ID: 38614151 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability. La Regina G; Bai R; Rensen W; Coluccia A; Piscitelli F; Gatti V; Bolognesi A; Lavecchia A; Granata I; Porta A; Maresca B; Soriani A; Iannitto ML; Mariani M; Santoni A; Brancale A; Ferlini C; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Novellino E; Silvestri R J Med Chem; 2011 Dec; 54(24):8394-406. PubMed ID: 22044164 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents. Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659 [TBL] [Abstract][Full Text] [Related]
20. Pyrimido[4,5-c]quinolin-1(2H)-ones as a novel class of antimitotic agents: Synthesis and in vitro cytotoxic activity. Metwally K; Pratsinis H; Kletsas D Eur J Med Chem; 2007 Mar; 42(3):344-50. PubMed ID: 17141923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]